Connect Biopharma Limite... (CNTB)

NASDAQ: CNTB · Real-Time Price · USD

0.83

0.01 (1.22%)

At close: May 02, 2025, 3:58 PM

0.80

-3.01%

After-hours: May 02, 2025, 05:37 PM EDT

Connect Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019
Net Income	-23.22M	7.65M	-28.8M	-30.58M	-56.68M	-61.92M	-56.65M	-145.71M	-107.85K	-10.64K	-12.23M	-12.23M
Depreciation & Amortization	183.53K	476K	481.87K	506.13K	527.3K	502.72K	412.05K	221.39K	160.54	55.91	57.3K	57.3K
Stock-Based Compensation	n/a	1.84M	3.26M	1.11K	1.43K	2.08K	2.9K	1.5K	3.62K	225.04	281.09K	281.09K
Other Working Capital	-82.08K	612K	13.99M	-1.27M	876.45K	2.47M	-2.33M	-724.62K	972.76	-240.32	-212.61K	-212.61K
Other Non-Cash Items	5.02M	-18.9M	-4.44M	2.16M	10.74M	856.07K	691.6K	108.04M	86.08K	4K	3.84K	3.84K
Deferred Income Tax	n/a	n/a	1.46M	-1.46M	-505.24K	2.12M	n/a	n/a	n/a	n/a	4.15M	4.15M
Change in Working Capital	2.44M	960K	11.2M	-1.72M	1.43M	5.59M	4.19M	-954.98K	503.85	-1.13K	1.19M	1.19M
Operating Cash Flow	-15.58M	-7.97M	-16.84M	-31.09M	-44.49M	-52.85M	-45.66M	-39.08M	-17.49K	-7.5K	-6.55M	-6.55M
Capital Expenditures	-312.08K	-436K	-8.33K	-285.67K	-2.46M	-1.74M	-315.65K	-7.07M	-2.24K	-48.55	-77.76K	-77.76K
Cash Acquisitions	n/a	n/a	2.96M	-16.5K	6.12K	35.82K	n/a	n/a	n/a	n/a	164.59	164.59
Purchase of Investments	-15.41M	n/a	-1.64M	-30.96M	-30.94M	-80.55M	-11.23M	-6.57M	n/a	n/a	-11.82M	-11.82M
Sales Maturities Of Investments	-39.7K	n/a	39.69M	65.5M	27.39M	6.48M	11.29M	8.61M	n/a	n/a	11.66M	11.66M
Other Investing Acitivies	44K	13.15M	-100.5K	16.5K	-6.12K	-35.82K	56.49	-702.95	2.03K	658.69	-164.59	-164.59
Investing Cash Flow	-15.72M	12.28M	40.9M	34.25M	-6M	-75.81M	-257.55K	-5.03M	-211.25	610.15	-242.35K	-242.35K
Debt Repayment	n/a	n/a	-290K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-31.8K	-31.8K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	-5.46K	-194.59	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	148K	-46K	61K	-61K	-59.03K	35.18K	-6.18M	-17.3M	140.78K	-31.56	3.5K	3.5K
Financial Cash Flow	272.42K	-46K	-115.72K	-130.28K	-124.69K	35.18K	979.46K	203.66M	140.78K	-31.56	-28.73K	-28.73K
Net Cash Flow	n/a	110.17M	27M	2.02M	-62.57M	-126.09M	-45.59M	159.55M	57.12K	-3.16K	-13.44M	-13.44M
Free Cash Flow	-15.89M	-8.41M	-16.85M	-31.37M	-46.94M	-54.59M	-45.97M	-46.15M	-19.73K	-7.55K	-6.62M	-6.62M